# Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure

> **NCT05816265** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Radha Gopalan** · enrollment: 40 (estimated)

## Conditions studied

- Heart Failure
- Iron-deficiency

## Interventions

- **DRUG:** IV Iron Infusion Group

## Key facts

- **NCT ID:** NCT05816265
- **Lead sponsor:** Radha Gopalan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-01-24
- **Primary completion:** 2026-03
- **Final completion:** 2027-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05816265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05816265, "Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05816265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*